- Home
- PHVS vs PENG Comparison
PHVS vs PENG Comparison
Compare PHVS & PENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHVS | PENG |
|---|---|---|
| Founded | 2015 | 1988 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.7B |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | PHVS | PENG |
|---|---|---|
| Price | $37.87 | $48.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 9 |
| Target Price | ★ $41.82 | $27.78 |
| AVG Volume (30 Days) | 1.0M | ★ 1.3M |
| Earning Date | 05-12-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 128.00 |
| EPS | N/A | ★ 1.29 |
| Revenue | N/A | ★ $1,368,794,000.00 |
| Revenue This Year | N/A | $14.55 |
| Revenue Next Year | N/A | $16.14 |
| P/E Ratio | ★ N/A | $36.82 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $20.65 | $16.04 |
| 52 Week High | $43.25 | $89.86 |
Technical Indicators
Market Signals| Indicator | PHVS | PENG |
|---|---|---|
| Relative Strength Index (RSI) | 59.67 | 41.67 |
| Support Level | $24.95 | $44.59 |
| Resistance Level | $43.25 | $53.73 |
| Average True Range (ATR) | 2.09 | 2.38 |
| MACD | 0.20 | -0.00 |
| Stochastic Oscillator | 45.08 | 21.94 |
Price Performance
Historical ComparisonAbout PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks. The company is also running open-label extension studies in both on-demand (RAPIDe-2) and prophylactic (CHAPTER-4) settings to collect long-term safety and efficacy data in HAE patients.
About PENG Penguin Solutions Inc. Ordinary Shares
Penguin Solutions Inc is an end-to-end technology company engaged in Intelligent Platform Solutions, Integrated Memory, and Optimized LED business. Its product include Servers, software, OCP HPC & AI system, Racks and Edge. Servers include AMD-based Serves, Intel-based Servers, etc. Software products include Scyld ClusterWare, Scyld Cloud Central, etc. OCP HPC & AI Systems includes OCP Servers & Storage and etc.